Atossa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.24%)
Atossa Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(7.7%)
Atossa Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.24%)
Atossa Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(7.7%)
Atossa Therapeutics | 4:持股變動聲明-董事 Finn Jonathan
Atossa Therapeutics | 4:持股變動聲明-董事 Remmel H. Lawrence
Atossa Therapeutics | 4:持股變動聲明-董事 Steinhart Richard I
Atossa Therapeutics | 4:持股變動聲明-董事 Chen Shu-Chih
Atossa Therapeutics | 4:持股變動聲明-高管 Rees Heather
Atossa Therapeutics | 4:持股變動聲明-高管 QUAY STEVEN C
Atossa Therapeutics | 4:持股變動聲明-董事 Galli Stephen J
Atossa Therapeutics | 4:持股變動聲明-董事 Cigler Tessa
Atossa Therapeutics | 4:持股變動聲明-董事 Finn Jonathan
Atossa Therapeutics | 4:持股變動聲明-董事 Cigler Tessa
Atossa Therapeutics | 3:首次持股聲明-董事 Cigler Tessa
Atossa Therapeutics | 4:持股變動聲明-高管 WEAVER GREGORY L
Atossa Therapeutics | 4/A:持股變動聲明(修正)-董事 Finn Jonathan
Atossa Therapeutics | 3:首次持股聲明-董事 Finn Jonathan
Atossa Therapeutics | 4:持股變動聲明-董事 Finn Jonathan
Atossa Therapeutics | 3:首次持股聲明-高管 Rees Heather
暫無數據